Aegerion raises $300M in bumped-up note deal

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) raised $300 million through the sale of senior convertible notes due 2019 to institutional investors. The notes bear 2% interest and initially convert at $4...